DAMORA THERAPEUTICS, INC. (DMRA) Free cash flow 2022–2023
DAMORA THERAPEUTICS, INC. (DMRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$37.1MFY2023 · since FY2022: -$43.2M → -$37.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$37.1M | +14.0% |
| FY2022 | -$43.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DMRA financial trends
DMRA RevenueDMRA Net incomeDMRA Net marginDMRA Gross profitDMRA Gross marginDMRA Operating incomeDMRA Operating marginDMRA Operating cash flowDMRA Capital expendituresDMRA Return on equityDMRA Stock buybacksDMRA Dividends paidDMRA Total assetsDMRA Total liabilitiesDMRA Shareholders’ equityDMRA overview →